Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
2.570
+0.050 (1.98%)
At close: May 29, 2026, 4:00 PM EDT
2.579
+0.009 (0.35%)
After-hours: May 29, 2026, 6:58 PM EDT

Intelligent Bio Solutions Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
3.913.053.111.260.441.98
Revenue Growth (YoY)
33.26%-1.90%147.58%187.52%-77.93%949.29%
Cost of Revenue
2.061.811.690.93--
Gross Profit
1.851.251.430.330.441.98
Selling, General & Admin
10.148.889.268.034.92-3.36
Depreciation & Amortization Expenses
1.181.211.20.97--
Research & Development
2.482.41.670.513.85-3.84
Other Operating Expenses
14.8312.9312.1317.828.77-7.91
Total Operating Expenses
28.6425.4224.2727.3217.55-15.11
Operating Income
-11.65-10.64-10.28-12.6-8.34-5.57
Interest Income
0.070.10.080.010.010.01
Interest Expense
-0.07-0.06-0.17-0.22-0.01-1.09
Other Non-Operating Income (Expense)
0.03-00.172.14-0-0.41
Total Non-Operating Income (Expense)
0.030.040.091.930-1.49
Pretax Income
-11.62-10.6-10.19-10.66-8.33-7.06
Net Income
-11.61-10.57-10.16-10.63-8.31-7.04
Minority Interest in Earnings
-0.01-----
Net Income to Common
-11.61-10.57-10.16-10.63-8.31-7.04
Shares Outstanding (Basic)
110000
Shares Outstanding (Diluted)
110000
Shares Change (YoY)
138.93%231.10%1802.54%37.00%40.81%22.38%
EPS (Basic)
-12.20-20.00-63.80-1270.00-1359.60-1632.00
EPS (Diluted)
-12.20-20.00-63.80-1270.00-1359.60-1632.00
Shares Outstanding
20.730.350.020.010.01
Free Cash Flow
-11.31-9.91-9.79-7.88-3.74-11.3
Free Cash Flow Per Share
-11.04-18.79-61.48-941.57-611.77-2603.15
Gross Margin
47.25%40.85%45.81%25.99%100.00%100.00%
Operating Margin
-297.81%-348.71%-330.46%-1002.11%-1907.11%-281.42%
Profit Margin
-297.81%-347.41%-327.50%-848.50%-1906.45%-356.49%
FCF Margin
-289.08%-324.62%-314.71%-627.15%-855.15%-570.39%
EBITDA
-10.49-9.43-9.07-11.63-8.34-5.57
EBITDA Margin
-268.04%-308.95%-291.48%-925.19%-1907.11%-281.42%
EBIT
-11.65-10.64-10.28-12.6-8.34-5.57
EBIT Margin
-297.81%-348.71%-330.46%-1002.11%-1907.11%-281.42%
SEC Filings: 10-K · 10-Q